2026 NPPES data Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician NPI 1538422357 MD
Verify on CMS →

STEPHANIE LLOP QUINTANA, MD

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 350 beneficiaries · Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician avg: 642
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$368.52
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEPHANIE LLOP QUINTANA, MD filed 1,618 Medicare Part D claims in 2023 as a Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician in MIAMI, Florida, prescribing 55% generic.

2K
Part D claims, 2023
55%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEPHANIE LLOP QUINTANA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,618 Top 18% higher than 82% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). This entry sits in this band. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

STEPHANIE LLOP QUINTANA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEPHANIE LLOP QUINTANA, MD?

Quality data not reported

NPI registry status

Active

Issued 06/18/2012

NPI 1538422357

Primary specialty

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician

Rare

37 US NPIs in this specialty

Medicare Part D claims

1,618 152% vs specialty avg

2023 prescription claims

Specialty avg: 642

Specialty distribution in Florida

How Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician compares to other specialties among Florida providers

Florida providers

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within Florida

1. Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician ABMS/AOA estimate

Est. board-certified rate (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHANIE LLOP QUINTANA, MD appears in the CMS NPPES registry as a Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider holding MD credentials at 900 NW 17TH ST, MIAMI, FL, 33136, with a listed phone of (305) 482-5401. NPI 1538422357 was issued on 06/18/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LLOP QUINTANA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,618 prescription claims written by this provider, covering 350 Medicare beneficiaries and totaling roughly $213K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician is a narrow specialty nationwide, with 37 enrolled providers across 15 states and an average of 642 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

900 NW 17TH ST
MIAMI, FL 33136

Provider Details

NPI 1538422357
Specialty Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 06/18/2012

Hospital and facility affiliations

Facilities where STEPHANIE LLOP QUINTANA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF MIAMI
CORAL GABLES, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHANIE LLOP QUINTANA, MD. Source: openpaymentsdata.cms.gov.

Total received

$369

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to STEPHANIE LLOP QUINTANA, MD. To verify STEPHANIE LLOP QUINTANA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

STEPHANIE LLOP QUINTANA, MD — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 1,618 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,618
Total Claims
$213K
Total Drug Cost
350
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,412
Total Day Supply
65,763
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$164K
Generic Drug Cost
$48K
Antibiotic Claims
27

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.73
Gender Split
63% female / 37% male
Age Distribution
<65: 37, 65-74: 157, 75-84: 118, 85+: 38

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEPHANIE LLOP QUINTANA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
415
Ketorolac Tromethamine
182
Moxifloxacin
Moxifloxacin Hcl
134
Latanoprost
100
Prednisone
96
Restasis
Cyclosporine
61
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
56
Methotrexate
Methotrexate Sodium
48
Valacyclovir
Valacyclovir Hcl
41
Brimonidine Tartrate
40

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Overview

How STEPHANIE LLOP QUINTANA, MD fits within the Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician landscape nationally.

37
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Providers in US
15
States with Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
642
Avg Claims per Provider

STEPHANIE LLOP QUINTANA, MD's 1,618 claims are above the specialty average of 642.

Nearby Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as LLOP QUINTANA.

Compare Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHANIE LLOP QUINTANA, MD's specialty?
STEPHANIE LLOP QUINTANA, MD specializes in Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician and practices in MIAMI, Florida. Credentials: MD.
How much does STEPHANIE LLOP QUINTANA, MD prescribe under Medicare Part D?
In 2023, STEPHANIE LLOP QUINTANA, MD wrote 1,618 Medicare Part D claims totaling $213K in drug costs for 350 beneficiaries.
Where is STEPHANIE LLOP QUINTANA, MD located?
STEPHANIE LLOP QUINTANA, MD is located at 900 NW 17TH ST, MIAMI, FL, 33136. Phone: (305) 482-5401.
What is STEPHANIE LLOP QUINTANA, MD's NPI number?
STEPHANIE LLOP QUINTANA, MD's National Provider Identifier (NPI) is 1538422357, issued on 06/18/2012.
Does STEPHANIE LLOP QUINTANA, MD prescribe more brand-name or generic drugs?
STEPHANIE LLOP QUINTANA, MD's prescribing is 45% brand-name and 55% generic drugs by claim count, with $164K in brand drug costs.
How many Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers are there in the US?
There are 37 Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers across 15 states in the US. The average Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider writes 642 Medicare Part D claims per year.
What drugs does STEPHANIE LLOP QUINTANA, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHANIE LLOP QUINTANA, MD's most frequently prescribed drugs include Prednisolone Acetate, Ketorolac Tromethamine, Moxifloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHANIE LLOP QUINTANA, MD accept Medicare?
STEPHANIE LLOP QUINTANA, MD appears in CMS Medicare data with 1,618 Part D claims and 350 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHANIE LLOP QUINTANA, MD's credentials?
STEPHANIE LLOP QUINTANA, MD's NPI is 1538422357 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology